NCT06702202View on ClinicalTrials.gov

Effect of Subarachnoid Block and Femoropopliteal Block to Limb Perfusion in PAD Patients

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
Peripheral Arterial DiseaseSubarachnoid BlockFemoropopliteal BlockTissue Oxygen Saturation
Interventions
DRUG

Mixture of local anesthetics

Marcaine® (bupivacaine HCl) 0,5% and Xylocaine® (Lidocaine HCL) 2% = 2:1 Given in Femoropopliteal block group (Group F)

DRUG

0.5% hyperbaric bupivacaine

Given in Subarachnoid block group (Group S)

Trial Locations (1)

10430

Cipto Mangunkusumo Cental National Hospital, Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER

NCT06702202 - Effect of Subarachnoid Block and Femoropopliteal Block to Limb Perfusion in PAD Patients | Biotech Hunter | Biotech Hunter